Synthetic Biology News and Research

RSS

NIH awards UCSF $15.4 million to set up new National Center for Systems Biology

Cell biologists at UCSF have received $15.4 million from the National Institutes of Health to set up one of two new National Centers for Systems Biology, to study how cells respond to their environment - an emerging field of research that could revolutionize medicine by creating "smart cells" to deliver medications and other therapeutics more effectively.

22 Sep 2010

Global regulator for DNA trade needed

Amid growing concern that synthetic life sciences pose biosecurity and biosafety risks, scrutiny is increasing into the burgeoning DNA sequence trade. Research published today in the Bulletin of the Atomic Scientists, published by SAGE, looks at the necessity of a global regulator for DNA trade, and the significant barriers to creating one.

17 Sep 2010

Synthetic biology survey reveals need for attention towards addressing biosafety, biosecurity risks

Synthetic biology defined as the design and construction of new biological parts, devices, and systems or re-design of existing natural biological systems for useful purposes holds enormous potential to improve everything from energy production to medicine, with the global market projected to reach $4.5 billion by 2015.

9 Sep 2010

Life Technologies second-quarter Non-GAAP revenue increases 8% to $906 million

Life Technologies Corporation today announced results for its second quarter ending June 30, 2010. Non-GAAP revenue for the second quarter was $906 million, an increase of 8 percent over the $839 million reported for the second quarter of 2009. Excluding the impact of currency and prior acquisitions and divestitures, organic revenue for the quarter grew 6 percent over the same period in the previous year.

30 Jul 2010

New initiative launched on biosafety

Remember chemistry sets, ham radio, amateur astronomy, and early computing? Well, now it is biology's turn. Today, over 2,000 people from around the world belong to the Do-It-Yourself Biology (DIYbio) community, working on everything from microbial fuel cells, low-cost lab equipment, environmental surveillance, personal bio-monitoring, to new treatments for diseases.

29 Jun 2010

Scientists manipulate simple bacteria into constructing internal compartments for biofuels, vaccines

Scientists at the University of Kent and University College Cork have manipulated simple bacteria into constructing internal compartments where biofuels and vaccines can be produced.

14 Jun 2010

New report compares U.S. and European funding for research related to synthetic biology

A new analysis by the Synthetic Biology Project at the Woodrow Wilson Center found that the U.S. government has spent around $430 million on research related to synthetic biology since 2005, with the Department of Energy funding a majority of the research. By comparison, the analysis indicated that the European Union and three individual European countries – the Netherlands, United Kingdom, and Germany – had spent approximately $160 million during that same period.

9 Jun 2010

Life Technologies makes equity investment in SGI

Life Technologies Corporation, a provider of innovative life science solutions, announced today that it has made an equity investment in Synthetic Genomics, Inc., a privately held company founded to commercialize synthetic genomic advances. Terms of the investment were not disclosed.

3 Jun 2010

Life Technologies acquires majority stake in Geneart

Life Technologies Corporation, a provider of innovative life science solutions, announced today that it has concluded its tender offer and acquired a majority stake in Geneart AG, the global leader of the synthetic gene market segment. The combination of Geneart with Life Technologies' resources and commercial capabilities creates a well-capitalized synthetic biology company with advanced technology and production capabilities, providing products to fuel innovation in this emerging field.

28 May 2010

New synthesized genome may lead to advances in health and biotechnology

The successful construction of a synthesized genome could enable new research and development of human therapies, biofuels, and biobased chemicals from renewable resources.

21 May 2010

BBSRC, EPSRC fund £1.5M for synthetic biology projects under EuroSYNBIO Programme

Four new projects, announced today, will develop biological methods that offer a new approach to antibiotic production, power generation for extremely small mechanical components, new classes of medicines and innovative techniques to study cell biology.

19 May 2010

Call for papers, panels and posters for 2010 Pacific Rim Summit now open

The Biotechnology Industry Organization invites leaders from the biotechnology, chemical and agricultural industries to submit proposals and abstracts for panels, individual papers, and posters for the 2010 Pacific Rim Summit on Industrial Biotechnology and Bioenergy. This unique conference will be held Dec. 11-14, 2010 in Honolulu.

17 May 2010

Researchers use nanofactories to prevent bacteria without using antibiotics

New research at the A. James Clark School of Engineering could prevent bacterial infections using tiny biochemical machines—nanofactories—that can confuse bacteria and stop them from spreading, without the use of antibiotics.

28 Jan 2010

New technology could aid in developing novel drugs and future gene therapies

Researchers in Manchester have successfully carried out the first rewire of genetic switches, creating what could be a vital tool for the development of new drugs and even future gene therapies.

From The University of Manchester 27 Jan 2010

New effort to produce standardized DNA parts for reducing development time of synthetic biology in labs

With seed money from the National Science Foundation (NSF), bioengineers from the University of California, Berkeley, and Stanford University are ramping up efforts to characterize the thousands of control elements critical to the engineering of microbes so that eventually, researchers can mix and match these "DNA parts" in synthetic organisms to produce new drugs, fuels or chemicals.

21 Jan 2010

Quorum sensing offers a dynamic approach to increase sensitivity to external signals

Researchers at UC San Diego who last year genetically engineered bacteria to keep track of time by turning on and off fluorescent proteins within their cells have taken another step toward the construction of a programmable genetic sensor. The scientists recently synchronized these bacterial "genetic clocks" to blink in unison and engineered the bacterial genes to alter their blinking rates when environmental conditions change.

21 Jan 2010

Synthetic Biology News and Research

NIH awards UCSF $15.4 million to set up new National Center for Systems Biology

Global regulator for DNA trade needed

Synthetic biology survey reveals need for attention towards addressing biosafety, biosecurity risks

Life Technologies second-quarter Non-GAAP revenue increases 8% to $906 million

New initiative launched on biosafety

Scientists manipulate simple bacteria into constructing internal compartments for biofuels, vaccines

New report compares U.S. and European funding for research related to synthetic biology

Life Technologies makes equity investment in SGI

Life Technologies acquires majority stake in Geneart

New synthesized genome may lead to advances in health and biotechnology

BBSRC, EPSRC fund £1.5M for synthetic biology projects under EuroSYNBIO Programme

Call for papers, panels and posters for 2010 Pacific Rim Summit now open

Researchers use nanofactories to prevent bacteria without using antibiotics

New technology could aid in developing novel drugs and future gene therapies

New effort to produce standardized DNA parts for reducing development time of synthetic biology in labs

Quorum sensing offers a dynamic approach to increase sensitivity to external signals

SynBIA formed to address the emergence of synthetic biology industry and to promote its potential

Scientists receive $3 million from NIH to uncover how plants make medicinal compounds

Americans want to be better informed about developments in cutting-edge technologies

G-bor Bal-zsi's innovative research in drug resistance earns select honor

eBook: Grow Your Synthetic Biology Processes to Leverage Success eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News